<mets:mets OBJID="eprint_1075" LABEL="Eprints Item" xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mets="http://www.loc.gov/METS/" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mets:metsHdr CREATEDATE="2026-07-05T00:19:43Z"><mets:agent ROLE="CUSTODIAN" TYPE="ORGANIZATION"><mets:name>Repositori BKPK</mets:name></mets:agent></mets:metsHdr><mets:dmdSec ID="DMD_eprint_1075_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:titleInfo><mods:title>Pengobatan Artesunat pada Penderita Malaria Falsiparum Tanpa Komplikasi di Daerah Resisten Multidrug</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Emiliana</mods:namePart><mods:namePart type="family">Tjitra</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Sri</mods:namePart><mods:namePart type="family">Oemijati</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Wita</mods:namePart><mods:namePart type="family">Pribadi</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">P.R.</mods:namePart><mods:namePart type="family">Arbani</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>A treatment trial of artesunate for uncomplicated falciparum malaria cases was conducted at ITCI Hospital, Balikpapan, East Kalimantan, Indonesia, in November 1992- Januari 1993. The objectives of this study were to assess the efficacy and safety of artesunate.      Thirty eight falciparum malaria patients who had been selected according to criteria for the in vivo sensitivity test were treated orally with 100 mg artesunate 12 hourly on D0 and followed 50 mg 12 hourly on D1-4. All patients were hospitalized until declared cured clinically and prasitologically.      The most prevalent clinical symptoms of these malaria patients were fever (84.2%), headache (81.6%), nausea (73.7%) and splenomegaly (71.0%). The cure rates of artesunate were 100% (38/38 and 28/28) on D7 and D14, but on D21 and D28 there were 88.2% (15/17) and 75% (6/8) because of the presence of late R1 cases. The mean fever clearance time (FCT) and parasite clearance time (PCT) were as fellows 15.1  1.8 h and 32.1  3.0 h (D7), 14.1  2.2 h and 33.3  3.8 h (D14), 15.7  3.0 h and 37.6  5.6 h (D21), 14.0  4.6 h and 32.0  5.9 h (D28) respectively. No side effect was found clinically and laboratory examinations.      Artesunate is effective and safe for treatment of uncomplicated falciparum malaria until D14 in a multidrug resistant area. A sequential combination of artesunate and other antimalarial drugs should be studied to achieve a radiccal cure.</mods:abstract><mods:classification authority="lcc">WC 680-950 Tropical and Parasitic Diseases</mods:classification><mods:originInfo><mods:dateIssued encoding="iso8601">1993</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Badan Penelitian dan Pengembangan Kesehatan</mods:publisher></mods:originInfo><mods:genre>Article</mods:genre></mets:xmlData></mets:mdWrap></mets:dmdSec><mets:amdSec ID="TMD_eprint_1075"><mets:rightsMD ID="rights_eprint_1075_mods"><mets:mdWrap MDTYPE="MODS"><mets:xmlData><mods:useAndReproduction>
<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by its own author:</strong>
In self-archiving this collection of files and associated bibliographic
metadata, I grant Repositori BKPK the right to store
them and to make them permanently available publicly for free on-line.
I declare that this material is my own intellectual property and I
understand that Repositori BKPK does not assume any
responsibility if there is any breach of copyright in distributing these
files or metadata. (All authors are urged to prominently assert their
copyright on the title page of their work.)</p>

<p xmlns="http://www.w3.org/1999/xhtml"><strong>For work being deposited by someone other than its
author:</strong> I hereby declare that the collection of files and
associated bibliographic metadata that I am archiving at
Repositori BKPK is in the public domain. If this is
not the case, I accept full responsibility for any breach of copyright
that distributing these files or metadata may entail.</p>

<p xmlns="http://www.w3.org/1999/xhtml">Clicking on the <em>Deposit Item Now</em> button indicates your agreement to these
terms.</p>
    </mods:useAndReproduction></mets:xmlData></mets:mdWrap></mets:rightsMD></mets:amdSec><mets:fileSec><mets:fileGrp USE="reference"><mets:file ID="eprint_1075_3309_1" SIZE="452889" OWNERID="http://www.badankebijakan.kemkes.go.id/repositori/id/eprint/1075/1/374-549-1-PB.pdf" MIMETYPE="application/pdf"><mets:FLocat LOCTYPE="URL" xlink:type="simple" xlink:href="http://www.badankebijakan.kemkes.go.id/repositori/id/eprint/1075/1/374-549-1-PB.pdf"></mets:FLocat></mets:file></mets:fileGrp></mets:fileSec><mets:structMap><mets:div DMDID="DMD_eprint_1075_mods" ADMID="TMD_eprint_1075"><mets:fptr FILEID="eprint_1075_document_3309_1"></mets:fptr></mets:div></mets:structMap></mets:mets>